Beta Bionics, Inc. is a commercial-stage medical device company. The company is headquartered in Irvine, California and currently employs 420 full-time employees. The company went IPO on 2025-01-30. The firm's product, the iLet Bionic Pancreas (iLet), is an insulin delivery device cleared by the United States Food and Drug Administration (FDA) to utilize adaptive closed-loop algorithms to autonomously determine every insulin dose without requiring a user to count carbohydrate intake. iLet is used for the treatment of Type 1 diabetes (T1D). The firm's solutions include iLet for Adults, iLet for Children, Bionic Circle App and iLet Simulator. The firm is in the early stages of developing an insulin pump that is designed to adhere directly to the skin and administer insulin without the need for tubing, commonly known in the diabetes industry as a patch pump. The company is also in the early stages of developing a bihormonal configuration of the iLet.
The current price of BBNX is $9.46, it has decreased 0% in the last trading day.
What are the primary business themes or industries for Beta Bionics Inc?
Beta Bionics Inc belongs to Health Care industry and the sector is Health Care
What is Beta Bionics Inc market cap?
Beta Bionics Inc's current market cap is $421.5M
Is Beta Bionics Inc a buy, sell, or hold?
According to wall street analysts, 14 analysts have made analyst ratings for Beta Bionics Inc, including 6 strong buy, 6 buy, 3 hold, 0 sell, and 6 strong sell